Table of Contents Table of Contents
Previous Page  19 / 154 Next Page
Show Menu
Previous Page 19 / 154 Next Page
Page Background

Speaker’s Biographies

Demetris Papamichael

Medical Oncology, Nicosia, Cyprus

Demetris Papamichael is Director of Medical Oncology at the Cyprus Oncology Centre in Nicosia, a post he has held since

1999. He obtained his medical degree from Charing Cross and Westminster Medical School, University of London in 1988. Dr

Papamichael trained in internal medicine and obtained his Membership of the Royal Colleges of Physicians (MRCP) in 1992.

His subsequent training in medical oncology was completed at the Royal Marsden and St Bartholomew’s Hospitals in London.

He became a Fellow of the Royal College (FRCP) in 2002. Dr Papamichael is an American Society of Clinical Oncology (ASCO)

Merit Award winner. He is an active researcher and has recently been involved in a number of clinical trials coordinated by

the European Organization for Research and Treatment of Cancer and the UK Medical Research Council/National Cancer

Research Institute (MRC/NCRI). In addition, he is involved in translational research projects in colorectal cancer.

Dr Papamichael’s main clinical interests include gastrointestinal cancer, gynae malignacies, and cancer in the elderly.

He has published his work in a number of peer-reviewed international journals. Dr Papamichael is actively involved in

the teaching and organization of courses run by the European School of Oncology (ESO) and EORTC. He is a member of

ASCO, the European Society of Medical Oncology (ESMO), and the International Society of Geriatric Oncology (SIOG).

Recently he headed a Task Force responsible for developing recommendations for the management colorectal cancer in

the elderly under the auspices of SIOG

Heather Payne

University College Hospital, London, Oncology, London, England

Heather Payne has been a Consultant in Clinical Oncology at University College Hospital, London, UK, since 1997. She

trained at St Mary’s Hospital, London and after qualifying, worked in general medicine in London and also in Haiti where

conventional medicine was mixed with voodoo practices. Prof. Payne returned to London to train as a clinical oncologist

and developed an interest in urological oncology. She now has a busy practice in a teaching hospital where she works

within a multidisciplinary team. Prof. Payne is actively involved in clinical research and has pioneered a programme of

high dose rate brachytherapy for prostate cancer. Her current research interests also include adjuvant hormone therapy,

predictive indices for bowel toxicity with radiotherapy, chemotherapy and quality of life, and decision-making for men

with prostate cancer. Prof. Payne is principal investigator in a number of international and local clinical studies. She is

a trustee of the Prostate cancer Research Centre and chair of the British Uro-Oncology Group. She also serves on the

Prostate Cancer Advisory Group in the UK and is the clinical lead for oncology the National Prostate Cancer Audit.

Speaker Abstract(s): S47

Fausto Roila

Medical Oncology Division, Department of Oncology, Terni, Italy

I am a medical oncologist that works as director in the Medical Oncology Division, S. Maria Hospital, Terni, Italy.

I am a member of the Board of the Multinational Association of Supportive Care in Cancer (MASCC)

Since 1981 I have dedicated myself to antiemetic research and as a leader of the Italian Group for Antiemetic Research

I have published a large number of scientific articles in the most prestigious medical journals.

I have been the Subject Editor of ESMO clinical recommendations on supportive/palliative care from 2006 to 2012.

I amamember of the Consultant Committee for the Oncological Drugs of the Italian Agency of the Drugs (A.I.F.A.), of the Ethical

Committee of Aziende Sanitarie of Umbria and of the Committee of Hospital Therapeutic Formulary of Umbria Region.

Speaker Abstract(s): S50

Siri Rostoft

Oslo University Hospital, Department of Geriatric Medicine, Oslo, Norway

Siri Rostoft is a medical doctor at Oslo University Hospital, Norway, specialized in internal medicine and geriatric

medicine. She completed her PhD about geriatric assessment in older surgical cancer patients in 2011, and works as an

assistant professor at the University of Oslo. Her main research interests in geriatric oncology are the clinical importance

of geriatric assessment and interventions and frailty. She is a deputy editor for

Journal of Geriatric Oncology.

Speaker Abstract(s): S51

Patrick Roth

University Hospital Zurich, Department of Neurology, Oslo, Norway

Dr. Patrick Roth is an Attending Physician at the Department of Neurology and the coordinating physician of the

Brain Tumor Center at the University Hospital Zurich, Switzerland. He specializes in the interdisciplinary management

of brain tumor patients. He is involved in various clinical trials as well as preclinical research aiming at developing

novel therapeutic strategies, with a particular focus on immunotherapeutic approaches for brain tumor patients. His

current research focuses are the mechanisms underlying glioma immune escape, novel approaches to enhance the

immunogenicity of glioma cells, and the analysis of new compounds for anti-glioma therapy.

Speaker Abstract(s): S52